← Back to Clinical Trials
Recruiting NCT07379723

NCT07379723 Brief Intervention for FCD: A Feasibility Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07379723
Status Recruiting
Phase
Sponsor King's College Hospital NHS Trust
Condition Functional Cognitive Disorder
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-11-11
Primary Completion 2026-03-13

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Brief psychological intervention including attention training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-11-11 with a primary completion date of 2026-03-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to learn if a single session intervention for people with Functional Cognitive Disorder (FCD) is feasible and acceptable. The main questions it aims to answer are: What is the impact of a single session intervention on FCD symptoms, functional impairment, and quality of life in people with FCD? What is the feasibility and acceptability of piloting a single session intervention for people with FCD. Participants will: * Complete questionnaires about cognitive concerns, anxiety, depression, functional impairment and quality of life * Visit the clinic for a single session intervention including practicing the Attention Training Technique (ATT) * Complete 2 telephone calls with a researcher to discuss their use of the intervention and to complete the same questionnaires from their clinic visit, and a questionnaire about their experience of the study and intervention.

Eligibility Criteria

Inclusion Criteria: * Adults aged 65 or below * Meet criteria for diagnosis of FCD (criteria include normal MRI results with no neurological diagnosis, and symptoms that are not explained by any other medical condition, performance at routine pre-baseline neuropsychological assessment within the service) * Not taking part in any other intervention study or trial Exclusion Criteria: * Aged above 65 years * Lack capacity to consent * MRI results not in normal range * Neurological diagnosis * Indication of severe low mood or depression (from clinical interview, routine measures) * Taking part in any other intervention study or trial

Frequently Asked Questions

Who can join the NCT07379723 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Functional Cognitive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07379723 currently recruiting?

Yes, NCT07379723 is actively recruiting participants. Visit ClinicalTrials.gov or contact King's College Hospital NHS Trust to inquire about joining.

Where is the NCT07379723 trial being conducted?

This trial is being conducted at London, United Kingdom.

Who is sponsoring the NCT07379723 clinical trial?

NCT07379723 is sponsored by King's College Hospital NHS Trust. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology